NCT03556137View on ClinicalTrials.gov

PET/MRI in the Diagnosis of Chronic Pain

PHASE1UnknownINTERVENTIONAL
Enrollment

190

Participants

Timeline

Start Date

July 16, 2018

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Neuropathic PainNociceptive PainMixed Pain (Nociceptive and Neuropathic)Spinal PainRadiculopathyMyelopathyNeurogenic Claudication
Interventions
DRUG

[18F]FTC-146

Adult participants will be injected with 5-10 mCi of \[18F\]FTC-146 and undergo a PET/MRI scan.

Trial Locations (1)

94305

RECRUITING

Stanford University, Stanford

Sponsors

Collaborators (1)

GE Healthcare
All Listed Sponsors
collaborator

GE Healthcare

INDUSTRY

lead

Stanford University

OTHER